Patent details

EP2784084 Title: Antagonist antibodies to IL-17A/F heterologous polypeptides

Basic Information

Publication number:
EP2784084
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP141636860
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Antagonist antibodies to IL-17A/F heterologous polypeptides
French Title of Invention:
Polypeptides hétérologues IL-17 A/F et utilisations thérapeutiques associées
German Title of Invention:
Heterologe IL-17A/F-Polypeptide und deren therapeutische Verwendungen
SPC Number:
LUC00143
LUC00144

Dates

Filing date:
02/06/2004
Grant date:
24/07/2019
EP Publication Date:
01/10/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2019
EP B1 Publication Date:
24/07/2019
EP B2 Publication Date:
04/10/2023
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/06/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/09/2023
 
 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

History of Owners

From:
02/11/2020
To:
20/11/2020

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:
17/07/2019
To:
02/11/2020

Name:
Genentech, Inc.
Address:
1 DNA Way, South San Francisco, CA 94080-4990, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
04/09/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Gurney, Austin
Address:
United States (US)

2

Name:
Lee, James
Address:
United States (US)

3

Name:
Hass, Phillip
Address:
United States (US)

4

Name:
Wu, Yan
Address:
United States (US)

5

Name:
Arnott, David
Address:
United States (US)

Priority

1

Priority Number:
485599 P
Priority Date:
08/07/2003
Priority Country:
United States (US)

2

Priority Number:
486457 P
Priority Date:
11/07/2003
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/24; A61K 39/395;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2020/13
Publication date:
07/12/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
201930
Publication date:
24/07/2019
Description:
Grant (B1)

2

Issue number:
202023
Publication date:
03/06/2020
Description:
Opposition procedure started

3

Issue number:
202022
Publication date:
27/05/2020
Description:
Opposition procedure started

4

Issue number:
202017
Publication date:
22/04/2020
Description:
Opposition procedure started

5

Issue number:
201935
Publication date:
28/08/2019
Description:
Opposition procedure started

6

Issue number:
202340
Publication date:
04/10/2023
Description:
Patent maintained (B2 publication)

7

Issue number:
202310
Publication date:
08/03/2023
Description:
Title of invention Modified

8

Issue number:
202052
Publication date:
23/12/2020
Description:
Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20200000345A
Date Registered:
02/11/2020
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
NOVARTIS PHARMA AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/05/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
10/11/2020 Outgoing Correspondence 1
02/11/2020 Request For Change 11
18/09/2019 Outgoing Correspondence 1
04/09/2019 Power Of Attorney 1